İ. Tahralı Et Al. , " A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response," ECI 2021 , Belgrade, Serbia, pp.358, 2021
Tahralı, İ. Et Al. 2021. A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response. ECI 2021 , (Belgrade, Serbia), 358.
Tahralı, İ., Akdeniz, N., Öktelik, F. B., Küçüksezer, U. C., Çetin, E., Öğütmen, Y., ... Öncül, M. O.(2021). A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response . ECI 2021 (pp.358). Belgrade, Serbia
Tahralı, İlhan Et Al. " A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response," ECI 2021, Belgrade, Serbia, 2021
Tahralı, İlhan Et Al. " A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response." ECI 2021 , Belgrade, Serbia, pp.358, 2021
Tahralı, İ. Et Al. (2021) . " A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response." ECI 2021 , Belgrade, Serbia, p.358.
@conferencepaper{conferencepaper, author={İlhan TAHRALI Et Al. }, title={ A possible therapeutic agent for hyperinflammation in COVID‐19: C‐Vx directs T cells to display an anti‐inflammatory immune response}, congress name={ECI 2021}, city={Belgrade}, country={Serbia}, year={2021}, pages={358} }